Abstract
ABSTRACTThe ability to introduce mutations, or transgenes, of choice to precise genomic locations has revolutionised our ability to understand how genes and organisms work.In many mosquito species that are vectors of various human disease, the advent of CRISPR genome editing tools has shed light on basic aspects of their biology that are relevant to their efficiency as disease vectors. This allows a better understanding of how current control tools work and opens up the possibility of novel genetic control approaches, such as gene drives, that deliberately introduce genetic traits into populations. Yet for the Anopheles funestus mosquito, a significant vector of malaria in sub-Saharan Africa and indeed the dominant vector species in many countries, transgenesis has yet to be achieved.We describe herein an optimised transformation system based on the germline delivery of CRISPR components that allows efficient cleavage of a previously validated genomic site and preferential repair of these cut sites via homology-directed repair (HDR), which allows introduction of exogenous template sequence, rather than end-joining repair. The rates of transformation achieved are sufficiently high that it should be able to introduce alleles of choice to a target locus, and recover these, without the need to include additional dominant marker genes. Moreover, the high rates of HDR observed suggest that gene drives, which employ an HDR-type mechanism to ensure their proliferation in the genome, may be well suited to work in An. funestus.
Publisher
Cold Spring Harbor Laboratory
Reference39 articles.
1. Akbari, Omar S. , Philippos A. Papathanos , Jeremy E. Sandler , Katie Kennedy , and Bruce A. Hay . 2014. ‘Identification of germline transcriptional regulatory elements in Aedes aegypti’, Scientific Reports, 4.
2. Stable, Germ-Line Transformation ofCulex quinquefasciatus(Diptera: Culicidae)
3. Opinion: Standardizing the definition of gene drive
4. Benedict, M. Q. 2007. ‘Microinjection Methods for Anopheles Embryos.’ in, Methods in Anopheles Research (Malaria Research and Reference Reagent Centre MR4).
5. Site-specific genetic engineering of the Anopheles gambiae Y chromosome